b-to-v Partners
b-to-v Partners is a seed to Series C stage investment firm. It has made 9 investments. 33% of their portfolio is in Healthcare. Average disclosed round size is $38.6M (across 4 rounds with reported amounts).
Portfolio
9
Fund Size
—
Top Stage
Series C
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
12 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 UroMems | Series C | $47M | Jun 2024 |
 Altoida | Series A | $14M | Jan 2024 |
 COMPEON | Series C | — | Jan 2021 |
 Bux | Series C | $80M | Jan 2021 |
 Araris Biotech | Seed | — | Oct 2020 |
 Araris | Seed | — | Oct 2020 |
| GGNA Biosolutions | Series C | $13.5M | Aug 2019 |
 Campanda | Series A | — | May 2015 |
| COMPEON | Series A | — | Jan 2015 |
 AYOXXA | Series B | — | Jun 2014 |
| GGNA Biosolutions | Series B | — | — |
| Campanda | Series B | — | — |
Top Co-Investors
Vi Partners3 shared
4BIO Capital2 shared
Redalpine2 shared
Pureos Bioventures2 shared
Robert Bosch Venture Capital2 shared
Wellington Management2 shared
Tengelmann Ventures2 shared
NRW.BANK2 shared
Accel2 shared
Atlantic Labs2 shared
Ringier Digital Ventures2 shared
KfW2 shared
Schroders Capital1 shared
SHS Capital1 shared
ABN AMRO Ventures1 shared
Citius1 shared
Prosus Ventures1 shared
HV Capital1 shared
Bpifrance1 shared
Last updated: 27 September 2026